LKP Solutions Inc. (“LKP” or the “Company”) is pleased to announce that it has signed a definitive business combination agreement effective as of July 11, 2018 (the “BCA”), whereby LKP will acquire all of the issued and outstanding securities of Osoyoos Cannabis Inc. (“OSO”) by way of a three-cornered amalgamation among LKP, 1160516 B.C. Ltd. (a wholly-owned subsidiary of LKP) and OSO (the “Transaction”). The Transaction will constitute a reverse takeover under applicable securities laws.

The BCA supersedes and replaces the share exchange agreement originally announced by LKP on September 12, 2017.

OSO is an Oliver, B.C. based cannabis company focused on obtaining a cultivation license pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) as well as a license to produce cannabis reductions, as contemplated by the Cannabis Act (Canada) recently passed by Canada’s House of Commons.


Pursuant to the Transaction:

  1. LKP will consolidate its 16,407,054 issued and outstanding shares on the basis of 2 ½ existing common shares for each post-consolidated LKP common share (an “LKP Share”);
  2. 1160516 B.C Ltd. will formally amalgamate with OSO at which time LKP will then acquire 100% of the issued and outstanding shares of OSO by issuing one (1) LKP Share for each OSO share. As at the date hereof, it is anticipated that 24,504,861 LKP common shares at an ascribed value of $11,027,187.00 will be issued to the current shareholders of OSO.
  3. All OSO share purchase warrants will be exchanged on the basis of one LKP share purchase warrant for each OSO share purchase warrant. An LKP warrant will entitle the holder to acquire one LKP Share. As at the date hereof, it is anticipated that 34,295,691 LKP share purchase warrants will be issued;
  4. An additional 6,833,333 LKP Shares will be reserved for issuance pursuant to a conversion feature on $1,025,000 of OSO convertible debentures
  5. The name of LKP will be changed to “Osoyoos Cannabis Inc.” or to such other name as approved by the board of directors of the resulting issuer and the Registrar of Companies; and
  6. The board of directors of LKP will be reconstituted with directors nominated by OSO.

The anticipated pro forma capitalization of LKP after giving effect to the Transaction is set forth below:

Security Number
Common Shares 31,067,683
Share Purchase Warrants 35,116,589
Common Shares Reserved for Issuance 6,833,333



OSO, a British Columbia company, is a holding company that conducts operations through its wholly-owned subsidiary, Bare Root Production Osoyoos Inc. (“BRPO”).

BRPO submitted an application to become a licensed producer under the ACMPR in the spring of 2017; as amended in December 2017. The application is currently in the Detailed Review and Initiation of Security Clearance Process stage of the licensing process.

BRPO intends to lease approximately 2.69 acres of land near Oliver for the purposes of constructing a 9,000 square foot growing facility.

BPRO also intends to lease a close proximity warehouse space (approximately 10,000 square feet) in which it will produce cannabis extracts derived from raw cannabis flower initially sourced from other licensed producers and delivered to BRPO’s facility in Osoyoos.

In this regard, a separate application is in process under the Access to Cannabis for Medical Purposes Regulations and the Cannabis Act to allow cannabis extraction operations alongside cultivation.


OSO’s leadership team includes the following seasoned executives:

Gerald Goldberg, Executive Chairman, Director
Roger Dent, Director
Ernie Eves, Director
Sara Lee Irwin, Director
John McMahon, Director

Upon closing of the Transaction, it is expected that the OSO leadership team above will appoint additional management to the resulting issuer. The Board of Directors of the resulting issuer will include at least two of whom are “independent” of the resulting issuer within the meaning of National Instrument 52-110 – Audit Committees.


Subject to receipt of shareholder approval, LKP intends to: (a) change its name to “Osoyoos Cannabis Inc.” (or such other name as may be designated by OSO and accepted by the B.C. Company Registrar); (b) consolidate its outstanding common shares on a 2.5:1 basis; (c) approve the creation of a new stock option plan; (d) appoint auditors; and (e) approve certain administrative amendments to LKP’s Articles including the implementation of an advance notice provision for the election of directors.

LKP has tentatively re-scheduled its annual special meeting (see the Company’s news release of October 10, 2017) as follows:

Record date: July 17, 2018
Material Mail Date: August 1, 2018
Meeting Date: August 31, 2018

LKP is currently preparing an information circular for the LKP shareholder’s meeting which will be submitted to the B.C. Securities Commission (the “BCSC”) for review prior to dissemination as part of an ongoing continuous disclosure review. The information circular is expected to contain prospectus level disclosure on OSO and the Transaction. The foregoing dates are subject to adjustment as a result of the BCSC review.

The Transaction is an arm’s length transaction.


Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the intention of the parties to complete the Transaction. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.


“Robin Dow”

For further information contact:
Robin Dow, Chairman and CEO
C. 604-355-9986


CanBud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“CanBud” or the “Corporation”) is pleased to announce that it has closed the final tranche of its oversubscribed non-brokered private placement for aggregate gross proceeds of approximately $4,730,000 (the “Offering”).

The Corporation issued a combined total of 39,409,346 units (each a “Unit“) at price of $0.12 per Unit, with each Unit comprised of one common share in the capital of the Corporation (each a “Common Share“) and one common share purchase warrant (each a “Warrant“). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of $0.22 within 24 months of the closing of the Offering (the “Warrant Term“), provided, however that if the closing price of the Common Shares on the Canadian Securities Exchange (the “CSE“) (or any such other stock exchange in Canada as the Common Shares may trade at the applicable time) is $0.25 or greater per Common Share for a period of five (5) consecutive trading days at any time after the closing date of the Offering, the Corporation may accelerate the Warrant Term such that the Warrants shall expire on the date which is 30 days following the date a press release is issued by the Corporation announcing the reduced warrant terms.

Keep reading... Show less

Thoughtful Brands Inc. (CSE:TBI)(FSE:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands) announces that the letter of intent with Franchise Cannabis Corp. (“FCC”), previously announced in January, has been terminated. The previously announced European joint venture with FCC will continue and allow the Company to launch and tailor its products to European consumer demands

In connection with termination of the merger transaction with FCC, the Company has agreed to pay FCC $100,000 in cash and to issue FCC 5,000,000 common shares of the Company at a deemed value of $0.05 per share. The common shares will be subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws.

Keep reading... Show less

Mergers and acquisitions (M&A) in cannabis space have helped boost the industry to new levels.

Keep reading... Show less

Strategic sale of non-core assets by Lobe adds non-dilutive capital and shareholder value

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce, further to its press release dated February 23, 2021, that it has completed the sale to Ionic Brands Corp. (“Ionic Brands”) of Lobe’s non-core cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) held by Lobe’s subsidiary vendor, Green Star Biosciences Inc. (the “Transaction”).

Keep reading... Show less

Adding to its existing presence on the west coast of the United States, all five KOIOS™ flavours and all four Fit Soda™ flavours will be carried in Metropolitan Market stores beginning on Monday, March 22, 2021. Serving the Seattle-Tacoma area (population 3.87 million), Metropolitan Market is one of five chains under its parent firm Good Food Holdings, which has a total of 51 stores in California, Oregon, and Washington State.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that beginning on Monday, March 22, 2021, Koios’ entire line of canned beverage products will be sold at all locations of Metropolitan Market, an urban format supermarket chain in the Seattle-Tacoma area of Washington State. In Q1 2021, the Company announced multiple placements of its beverage products with regional grocers in markets on the west coast of the United States including Market of Choice in Oregon Jensen’s in Southern California and major natural grocery chain Sprouts Farmers Market which has a substantial west coast presence with over one third of its locations (360+ stores across 23 states) in California as well as Washington State 1 . The Company has also recently announced other developments relating to its expansion efforts being undertaken in 2021 such as an in-house beverage canning facility and distribution agreements with regional and national wholesale partners.

Keep reading... Show less